Category: Manufacturing

Manufacturing, Research and Development

After COVID-19 spotlighted supply chain weaknesses, Biden unveils plan to resurrect U.S. drug manufacturing

June 8, 2021

Via: FiercePharma

After investigating America’s supply chains, including those for drugs and pharmaceutical ingredients, the Biden administration has revelations to share—and it’s proposing a sweeping strategy to boost domestic drug production. Under the plan, the White House is establishing a public-private partnership […]

Clinical Trials, Manufacturing, Research and Development

Recro to Expand its Clinical Trial Services Offerings

June 3, 2021

Via: Biopharm International

Recro Pharma, a contract development and manufacturing organization (CDMO), announced on June 2, 2021 that it has expanded the clinical capabilities of its clinical trial services (CTS) offerings. The added capabilities include clinical-scale sachet and blister packaging for clinical trial […]

Manufacturing, News, Research and Development

Moderna ramps up EU COVID jab capacity via Lonza deal

June 2, 2021

Via: Pharmaphorum

The increased capacity depends on Moderna getting approval for a half dose of an updated version of the mRNA-1273 vaccine – targeting new variants of SARS-CoV-2 – that could be used as a booster shot and for immunising children. The […]

Manufacturing, Research and Development

Biogen’s $1B Swiss plant scores regulatory nod as drugmaker awaits pivotal FDA decision on aducanumab

May 25, 2021

Via: FiercePharma

Despite a flurry of uncertainty surrounding Biogen’s Alzheimer’s hopeful aducanumab, the company has forged ahead with its launch preparations ahead of a pending FDA decision. Now, its Swiss manufacturing facility is a step closer to eventually churning out doses—should the […]

Industry, Manufacturing, Research and Development, Vaccines

Oxford Biomedica to manufacture more doses of AstraZeneca’s Covid-19 vaccine

May 18, 2021

Via: EPM Magazine

Oxford Biomedica signed an 18-month supply agreement in September 2020 with AstraZeneca for the large-scale commercial manufacture of the adenovirus vector-based Covid-19 vaccine, AZD1222. AstraZeneca has now requested that Oxford Biomedica increase the number of batches it is manufacturing in […]

Manufacturing, Mergers and Acquisitions, News, Research and Development

Samsung and TG Therapeutics to Expand mAb Manufacturing Collaboration

April 27, 2021

Via: Biopharm International

Samsung Biologics announced on April 26, 2021 that it has expanded its 2018 contract manufacturing deal with TG Therapeutics, a US based healthcare company, for the supply of TG’s ublituximab, an investigational anti-CD20 monoclonal antibody (mAb). Since the start of […]

Manufacturing, News, Research and Development

Pharmaceutical Contract Development and Manufacturing Market | Exclusive Report on the Latest Trends and Market Revenues

April 8, 2021

Via: BioSpace

The rising popularity of outsourcing implementations across the healthcare industry due to the benefits such as affordability and less-time consumption will serve as a vital growth prospect for the pharmaceutical contract development and manufacturing market during the forecast period of […]

Biotech, Industry, Manufacturing, News, Research and Development, Vaccines

Emergent BioSolutions On Track with Respect to COVID-19 Contractual Commitments

April 5, 2021

Via: BioSpace

Emergent BioSolutions Inc. (NYSE:EBS) today announced that the Company continues to be on track with its manufacturing agreements related to COVID-19 vaccines and confirmed that there are no changes to its financial guidance for 2021. In addition, the Company received […]

Industry, Manufacturing, Research and Development, Vaccines

Increase in vaccine manufacturing capacity and supply for COVID-19 vaccines from AstraZeneca, BioNTech/Pfizer and Moderna

March 29, 2021

Via: World Pharma News

EMA’s human medicines committee (CHMP) has adopted several important recommendations that will increase manufacturing capacity and supply of COVID-19 vaccines in the EU. New manufacturing site for AstraZeneca’s COVID-19 vaccine A new manufacturing site has been approved for the production […]

Manufacturing, Research and Development

Nexus Pharmaceuticals Announces Verbal to Occupy Authorization

March 26, 2021

Via: BioSpace

Lincolnshire, Illinois—Nexus Pharmaceuticals, Inc. is pleased to announce that it has received authorization to occupy its new pharmaceutical manufacturing facility from the Village of Pleasant Prairie, Wisconsin. Nexus Pharmaceuticals, which specializes in developing innovative processes to manufacture specialty and generic […]

Manufacturing, Research and Development

Researchers Engineer E. coli for Animal-Free Drug Manufacturing

March 3, 2021

Via: Genetic Engineering and Biotechnology News

Chondroitin sulfate is an important structural component of cartilage and is naturally found in connective tissues in the human body and in animal cartilage. It is part of a protein molecule that helps give cartilage its elastic properties and is […]

Cell and Gene Therapy, Industry, Manufacturing, Research and Development

Rentschler Biopharma to build cell and gene therapy manufacturing capabilities in the UK

February 11, 2021

Via: Pharma Times

As part of the agreement, Rentschler will invest in the site over the next five years to bolster their manufacturing capabilities. This investment is expected to make a ‘major contribution’ to creating suitable manufacturing capability for cell and gene therapies, […]